Viewing Study NCT06704659


Ignite Creation Date: 2025-12-24 @ 3:00 PM
Ignite Modification Date: 2026-01-01 @ 11:23 AM
Study NCT ID: NCT06704659
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-11-26
First Post: 2024-11-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study on Recurrent Breast Cancer and Repeated Radiation Therapy
Sponsor: Turku University Hospital
Organization:

Study Overview

Official Title: Study on Recurrent Breast Cancer and Repeated Radiation Therapy
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RAY-no-BAN
Brief Summary: This study explores whether recurrent breast cancer can be safely treated with breast-conserving surgery and repeated radiation therapy in cases where patients have previously undergone radiation. Traditionally, recurrent breast cancer has been treated by removing the entire breast. However, recent research has shown that in certain situations, it may be possible to preserve the breast.

The study will collect data on the safety of this treatment approach and its effects on patients. The treatment follows standard breast cancer care practices, involving 30 patients from Helsinki and Turku University Hospitals. Patients are carefully selected based on specific criteria, such as tumor size, localization, and prior treatment history. Special attention is given to the planning of radiation therapy and surgical techniques.

The goal is to develop new treatment strategies that allow breast preservation even in cases of recurrent breast cancer, providing patients with high-quality and individualized care.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: